Skip to main content
OpenTrials
Completed

NCT Number: NCT05836181

The Effect of Eye Movement Desensitization and Reprocessing Intervention in Hypertension Patient.

Eye Movement Desensitization and Reprocessing intervention may improve anxiety, depression, systolic blood pressure and heart rate variability in patients with hypertension.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Eye Movement Desensitization and Reprocessing Intervention Anxiety Anxiety Disorders Blood Pressure Heart Rate Variability Mental Disorders

Age range

20 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Chen, miao-yi

Taipei, Neihu, 114, Taiwan

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age of 20-80 years,
  • diagnosed with primary hypertension as in SBP ≥130 mmHg or DBP ≥80 mmHg,
  • and able to read and understand Chinese or Taiwanese and willing to participate in this study,

Exclusion criteria

  • . Secondary hypertension
  • . Hypertension Crisis.

Treatment and study plan

Eye Movement Desensitization and Reprocessing

Behavioral

Effects of Eye Movement Desensitization and Reprocessing on Anxiety, Depression, Quality of Life, Blood Pressure and Heart Rate Variability in Patients with Hypertension.

Primary outcomes

  1. Anxiety

    Time frame: Six month

    HADS-A score

  2. depression symptoms

    Time frame: Six month

    CESD Scale

Secondary outcomes

  1. Blood pressure

    Time frame: Six month

    Blood pressure

Sponsors and collaborators

Lead sponsor

Miao-Yi Chen

Other

Registry information

Official study title

The Effect of Eye Movement Desensitization and Reprocessing Reducing Anxiety, Depressive Symptoms, Blood Pressure, and Heart Rate Variability in Primary Hypertension： A Randomized Controlled Clinical Trial

Acronym: EMDR

Important dates

Study start
2014
Primary completion
2016
Study completion
2016
First posted
May 1, 2023
Registry last updated
May 1, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.